Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TPGS2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
TBC1D2B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LRRC31 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GBX2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MRE11A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC100509457 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZNF506 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
EFNB2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LRRK1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SDHAP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CATSPERB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
JTB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WHRN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ID2B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CLDN16 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DNAAF5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IPO4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on